Literature DB >> 25344270

Systemic oxidative-nitrosative-inflammatory stress during acute exercise in hypoxia; implications for microvascular oxygenation and aerobic capacity.

John D S Woodside1, Mariusz Gutowski2, Lewis Fall3, Philip E James4, Jane McEneny5, Ian S Young5, Shigehiko Ogoh6, Damian M Bailey7.   

Abstract

Exercise performance in hypoxia may be limited by a critical reduction in cerebral and skeletal tissue oxygenation, although the underlying mechanisms remain unclear. We examined whether increased systemic free radical accumulation during hypoxia would be associated with elevated microvascular deoxygenation and reduced maximal aerobic capacity (V̇O2 max ). Eleven healthy men were randomly assigned single-blind to an incremental semi-recumbent cycling test to determine V̇O2 max in both normoxia (21% O2) and hypoxia (12% O2) separated by a week. Continuous-wave near-infrared spectroscopy was employed to monitor concentration changes in oxy- and deoxyhaemoglobin in the left vastus lateralis muscle and frontal cerebral cortex. Antecubital venous blood samples were obtained at rest and at V̇O2 max to determine oxidative (ascorbate radical by electron paramagnetic resonance spectroscopy), nitrosative (nitric oxide metabolites by ozone-based chemiluminescence and 3-nitrotyrosine by enzyme-linked immunosorbent assay) and inflammatory stress biomarkers (soluble intercellular/vascular cell adhesion 1 molecules by enzyme-linked immunosorbent assay). Hypoxia was associated with increased cerebral and muscle tissue deoxygenation and lower V̇O2 max (P < 0.05 versus normoxia). Despite an exercise-induced increase in oxidative-nitrosative-inflammatory stress, hypoxia per se did not have an additive effect (P > 0.05 versus normoxia). Consequently, we failed to observe correlations between any metabolic, haemodynamic and cardiorespiratory parameters (P > 0.05). Collectively, these findings suggest that altered free radical metabolism cannot explain the elevated microvascular deoxygenation and corresponding lower V̇O2 max in hypoxia. Further research is required to determine whether free radicals when present in excess do indeed contribute to the premature termination of exercise in hypoxia.
© 2014 The Authors. Experimental Physiology © 2014 The Physiological Society.

Entities:  

Mesh:

Year:  2014        PMID: 25344270     DOI: 10.1113/expphysiol.2014.081265

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  4 in total

1.  Exaggerated systemic oxidative-inflammatory-nitrosative stress in chronic mountain sickness is associated with cognitive decline and depression.

Authors:  Damian M Bailey; Julien V Brugniaux; Teresa Filipponi; Christopher J Marley; Benjamin Stacey; Rodrigo Soria; Stefano F Rimoldi; David Cerny; Emrush Rexhaj; Lorenza Pratali; Carlos Salinas Salmòn; Carla Murillo Jáuregui; Mercedes Villena; Jonathan D Smirl; Shigehiko Ogoh; Sylvia Pietri; Urs Scherrer; Claudio Sartori
Journal:  J Physiol       Date:  2018-11-24       Impact factor: 5.182

2.  Redox-regulation of haemostasis in hypoxic exercising humans: a randomised double-blind placebo-controlled antioxidant study.

Authors:  Lewis Fall; Julien V Brugniaux; Danielle Davis; Christopher J Marley; Bruce Davies; Karl J New; Jane McEneny; Ian S Young; Damian M Bailey
Journal:  J Physiol       Date:  2018-08-29       Impact factor: 5.182

3.  Effects of continuous hypoxia on flow-mediated dilation in the cerebral and systemic circulation: on the regulatory significance of shear rate phenotype.

Authors:  Takuro Washio; Benjamin S Stacey; Shigehiko Ogoh; Hayato Tsukamoto; Angelo Iannetelli; Thomas S Owens; Thomas A Calverley; Lewis Fall; Christopher J Marley; Damian M Bailey
Journal:  J Physiol Sci       Date:  2022-07-20       Impact factor: 2.257

4.  Effect of pre-term birth on oxidative stress responses to normoxic and hypoxic exercise.

Authors:  Agnès Martin; Grégoire Millet; Damjan Osredkar; Minca Mramor; Camille Faes; Etienne Gouraud; Tadej Debevec; Vincent Pialoux
Journal:  Redox Biol       Date:  2020-03-05       Impact factor: 11.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.